retatrutide expanded access compassionate use eli lilly Lilly's New Weight-Loss Treatment Shows Promising Results!! Retatrutide, designed to be taken once a week, met the primary endpoint in a phase 3 clinical. The initial TRIUMPH Phase 3 clinical development White House officials on Tuesday

A GLP-1 RA should be thought of as an addition to a healthy lifestyle, rather than a replacement

A separate Wegovy-related NAION lawsuit was also filed in New Jersey Superior Court the same month

PMID: 36075499 Yarur AJ, Bruss A, Moosreiner A, Beniwal-Patel P, Nunez L, Berens B, Colombel JF, Targan SR, Fox C, Melmed GY, Abreu MT, Deepak P

Studies finding protective effects against cancer: A meta-analysis found that two copies of the C677T variant (AA genotype) decrease the risk of colon cancer by about 20%![ref] Another meta-analysis found that two copies of the C677T variant (AA genotype) were protective against prostate cancer .[ref] The MTHFR C677T variant decreases the relative risk of retinoblastoma and oral squamous cell cancer.[ref][ref] Two copies of the C677T variant (AA genotype) are protective against gastric cancer.[ref] However, for someone who has cancer, the MTHFR C677T variant is associated with poorer outcomes.[ref] The MTHFR A1298C variant (GG or GT) is associated with a decreased risk of hypothyroidism .[ref] The flip side: Folate can also help protect against cancerous mutations in the first place